课题基金 / 基金详情

Pediatric Oncology Research Training Program

Pediatric Oncology Research Training Program
儿科肿瘤学研究培训计划
批准号:
10670428
负责人:
Elizabeth R Lawlor
金额:
$35.15万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
未结题
起止时间:
1979-08-01 至 2027-06-30

项目摘要

项目成果

Elizabeth R Lawlor的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The aim of this inter-disciplinary Pediatric Oncology Research Training (PORT) T32 application is to recruit and prepare highly qualified, motivated, and diverse physicians for a research-intensive career in Pediatric Oncology. Multiple reports have emphasized the dire shortage of pediatric oncologists that are well trained in laboratory or clinical research, those who will advance the field and be the next generation of leaders in enhancing care of children with cancer. It is increasingly important to retain the best and brightest trainees in research careers. Our PORT Program is integrated within our NCI-designated Cancer Center Consortium, comprising three academic partner institutions: the Fred Hutchinson Cancer Research Center (FHCRC), Seattle Children’s Hospital (SCH), and the University of Washington School of Medicine (UWSOM). This provides an unparalleled infrastructure to build on the 52-year history of our fellowship training program and 43 years of continuous funding of this T32 grant and continue to train the future leaders in pediatric oncology by recruiting the candidates with the highest academic ceiling and arming them with the most advanced research tools to ensure successful transition to independent research careers. This training program is available only to MD or MD-PhD-prepared applicants who have strong interest in a research-intensive career and provides opportunities for training in laboratory- based science as well as clinical research in outcome/survivorship/health disparity research. It offers support for 2 years of research training for 2 physician/scientists enrolled each year who have completed their first 12 months of clinical training in our ACGME-approved Pediatric Hematology Oncology Fellowship Program. Most of the trainee’s time is spent conducting research under the direct supervision of a faculty mentor(s) selected by the trainee with guidance from a specially selected Research Oversight Committee and the Executive Committee of the T32. Our program provides didactic teaching and a strong foundation in research design, develops the trainees’ ability to conceptualize and solve research problems, encourages increasing independence, provides training in state-of-the-art analytical techniques, requires trainees to present their research findings at scientific meetings and publish their results, and conveys an understanding of the relationship of the trainee’s research to health and disease. Our program consists of talented, well-funded and well-published mentors who are deployed across specific research pathways to expose trainees to diverse scientific questions, methodologies, and disease models. Longitudinal evaluation of the fellows and the program by Scholar Oversight Committees to ensure optimal training for the trainee and External Advisory Committee to help review and improve the program is intrinsic to the training program. Multiple institutional resources to enhance career development are available to allow all trainees to develop a customized training plan. Researchers trained in this program will be exceptional physician-scientists who are prepared for a career in a research-intensive setting in pediatric oncology, with highly developed research skills in cancer biology, diagnosis, prevention, therapy, and outcomes.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
Quantitative expression and function of differentiation antigens on normal and malignant lymphoid cells.
正常和恶性淋巴细胞上分化抗原的定量表达和功能。
DOI: 10.1007/978-3-642-70385-0_94
发表时间: 1985
期刊: Haematology and blood transfusion
影响因子: --
作者: [Clark,EA, Rose,LM, Shu,G, Dindorf,PA, Bernstein,ID, Ledbetter,JA]
通讯作者: Ledbetter,JA
The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.
便利队列的不便:横纹肌肉瘤和 PAX-FOXO1 生物标志物。
DOI: 10.1158/1055-9965.epi-12-0207
发表时间: 2012
期刊: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子: --
作者: [Rosenberg,AbbyR, Skapek,StephenX, Hawkins,DouglasS]
通讯作者: Hawkins,DouglasS
DOI: 10.1007/s00520-014-2249-5
发表时间: 2014-10
期刊: SUPPORTIVE CARE IN CANCER
影响因子: 3.1
作者: [Rosenberg, Abby R., Starks, Helene, Jones, Barbara]
通讯作者: Jones, Barbara
Effect of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymoma.
IL-2对SL-2胸腺瘤小鼠肿瘤和正常组织中单克隆抗体生物分布的影响。
DOI: 10.1093/jnci/84.2.109
发表时间: 1992
期刊: Journal of the National Cancer Institute
影响因子: --
作者: [Schultz,KR, Badger,CC, Dombi,GW, Greenberg,PD, Bernstein,ID]
通讯作者: Bernstein,ID
18
    Investigations of menin function in Ewing sarcoma
    • 批准号:
      10190642
    • 项目类别:
    • 资助金额:
      $56.17万
    • 财政年份:
      2020
    • 负责人:
      Elizabeth R Lawlor
    • 依托单位:
    Investigations of menin function in Ewing sarcoma
    • 批准号:
      10405129
    • 项目类别:
    • 资助金额:
      $50.47万
    • 财政年份:
      2020
    • 负责人:
      Elizabeth R Lawlor
    • 依托单位:
    Investigations of menin function in Ewing sarcoma
    • 批准号:
      10241553
    • 项目类别:
    • 资助金额:
      $52.16万
    • 财政年份:
      2020
    • 负责人:
      Elizabeth R Lawlor
    • 依托单位:
    Investigations of menin function in Ewing sarcoma
    海外基金